Jagsonpal [JAGSNPHARM] vs GPT Healthcare [GPTHEALTH] Detailed Stock Comparison

Jagsonpal

NSE
Loading...

GPT Healthcare

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Jagsonpal wins in 11 metrics, GPT Healthcare wins in 8 metrics, with 0 ties. Jagsonpal appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricJagsonpalGPT HealthcareBetter
P/E Ratio (TTM)26.5826.40GPT Healthcare
Price-to-Book Ratio6.735.08GPT Healthcare
Debt-to-Equity Ratio3.8514.24Jagsonpal
PEG Ratio0.25-1.18GPT Healthcare
EV/EBITDA26.9816.82GPT Healthcare
Profit Margin (TTM)21.50%11.44%Jagsonpal
Operating Margin (TTM)15.69%10.44%Jagsonpal
EBITDA Margin (TTM)15.69%10.44%Jagsonpal
Return on Equity23.07%20.14%Jagsonpal
Return on Assets (TTM)19.90%12.99%Jagsonpal
Free Cash Flow (TTM)$549.52M$174.71MJagsonpal
Dividend Yield0.36%1.57%GPT Healthcare
1-Year Return46.11%-17.46%Jagsonpal
Price-to-Sales Ratio (TTM)5.663.02GPT Healthcare
Enterprise Value$15.02B$12.61BJagsonpal
EV/Revenue Ratio5.313.03GPT Healthcare
Gross Profit Margin (TTM)64.39%61.63%Jagsonpal
Revenue per Share (TTM)$42$51GPT Healthcare
Earnings per Share (Diluted)$9.04$5.81Jagsonpal
Beta (Stock Volatility)0.23N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Jagsonpal vs GPT Healthcare Stock Performance Analysis

Loading Price Chart...

Jagsonpal
GPT Healthcare
Jagsonpal Stock Overview | GPT Healthcare Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Jagsonpal-1.14%0.22%-5.95%3.84%12.88%-7.51%
GPT Healthcare0.49%4.76%-1.94%2.70%11.70%-15.24%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Jagsonpal46.11%55.59%1,326.59%1,978.88%2,263.49%951.37%
GPT Healthcare-17.46%-19.01%-19.01%-19.01%-19.01%-19.01%

News Based Sentiment: Jagsonpal vs GPT Healthcare

Jagsonpal

News based Sentiment: POSITIVE

Jagsonpal Pharmaceuticals reported impressive Q1 FY26 results with significant revenue and profit growth, and set ambitious targets for the future. While a customs penalty exists, the company is actively addressing it. These factors combine to create a generally positive outlook for the company.

View Jagsonpal News Sentiment Analysis

GPT Healthcare

News based Sentiment: MIXED

GPT Healthcare reported revenue growth but experienced significant declines in EBITDA and net profit. While expansion plans and analyst forecasts offer some optimism, institutional selling and stock volatility create a mixed investment picture. The upcoming investor meet will be crucial for clarifying the company's strategy.

View GPT Healthcare News Sentiment Analysis

Performance & Financial Health Analysis: Jagsonpal vs GPT Healthcare

MetricJAGSNPHARMGPTHEALTH
Market Information
Market Cap i₹16.77B₹12.62B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i116,938235,367
90 Day Avg. Volume i525,668360,904
Last Close₹237.53₹156.02
52 Week Range₹153.10 - ₹328.04₹126.10 - ₹205.50
% from 52W High-27.59%-24.08%
All-Time High₹328.04 (Nov 25, 2024)₹219.90 (Feb 26, 2024)
% from All-Time High-27.59%-29.05%
Growth Metrics
Quarterly Revenue Growth0.23%0.10%
Quarterly Earnings Growth1.03%-0.23%
Financial Health
Profit Margin (TTM) i0.22%0.11%
Operating Margin (TTM) i0.16%0.10%
Return on Equity (TTM) i0.23%0.20%
Debt to Equity (MRQ) i3.8514.24
Cash & Liquidity
Book Value per Share (MRQ)₹35.72₹30.21
Cash per Share (MRQ)₹19.08₹4.44
Operating Cash Flow (TTM) i₹532.93M₹631.61M
Levered Free Cash Flow (TTM) i₹553.61M₹499.22M
Dividends
Last 12-Month Dividend Yield i0.36%1.57%
Last 12-Month Dividend i₹0.80₹2.50

Valuation & Enterprise Metrics Analysis: Jagsonpal vs GPT Healthcare

MetricJAGSNPHARMGPTHEALTH
Price Ratios
P/E Ratio (TTM) i26.5826.40
Forward P/E iN/A16.55
PEG Ratio i0.25-1.18
Price to Sales (TTM) i5.663.02
Price to Book (MRQ) i6.735.08
Market Capitalization
Market Capitalization i₹16.77B₹12.62B
Enterprise Value i₹15.02B₹12.61B
Enterprise Value Metrics
Enterprise to Revenue i5.313.03
Enterprise to EBITDA i26.9816.82
Risk & Other Metrics
Beta i0.23N/A
Book Value per Share (MRQ) i₹35.72₹30.21

Financial Statements Comparison: Jagsonpal vs GPT Healthcare

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)JAGSNPHARMGPTHEALTH
Revenue/Sales i₹756.12M₹1.07B
Cost of Goods Sold i₹269.27M₹410.93M
Gross Profit i₹486.85M₹660.15M
Research & Development iN/AN/A
Operating Income (EBIT) i₹118.60M₹111.83M
EBITDA i₹170.38M₹189.28M
Pre-Tax Income i₹144.31M₹111.14M
Income Tax i₹36.36M₹34.32M
Net Income (Profit) i₹107.95M₹76.82M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)JAGSNPHARMGPTHEALTH
Cash & Equivalents i₹112.15M₹16.59M
Total Current Assets i₹1.61B₹788.16M
Total Current Liabilities i₹259.04M₹742.43M
Long-Term Debt i₹76.32M₹227.25M
Total Shareholders Equity i₹2.40B₹2.48B
Retained Earnings iN/A₹887.46M
Property, Plant & Equipment i₹88.37M₹2.27B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)JAGSNPHARMGPTHEALTH
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricJAGSNPHARMGPTHEALTH
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i116,938235,367
Average Daily Volume (90 Day) i525,668360,904
Shares Outstanding i66.40M82.05M
Float Shares i16.17M26.93M
% Held by Insiders i0.76%0.68%
% Held by Institutions i0.03%0.13%

Dividend Analysis & Yield Comparison: Jagsonpal vs GPT Healthcare

MetricJAGSNPHARMGPTHEALTH
Last 12-Month Dividend i₹0.80₹2.50
Last 12-Month Dividend Yield i0.36%1.57%
3-Year Avg Annual Dividend i₹0.27₹1.67
3-Year Avg Dividend Yield i0.49%0.73%
3-Year Total Dividends i₹0.80₹5.00
Ex-Dividend DateSep 06, 2024Jul 29, 2025